Skip to main content
SpringerLink
Log in

PARP inhibitor-related haematological AEs

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Shu Y, et al. Hematological toxicities in PARP inhibitors: A real-world study using FDA adverse event reporting system (FAERS) database Cancer Medicine : 1 Aug 2022. Available from: URL: https://doi.org/10.1002/cam4.5062

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

PARP inhibitor-related haematological AEs. Reactions Weekly 1918, 12 (2022). https://doi.org/10.1007/s40278-022-20469-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-20469-8

Search

Navigation